Cardano Risk Management B.V.
Institutional investor · Portfolio as of Q2 2024
Top Holdings17 positions
Microsoft Corp. | 2.1M | $933M | 18.3% | $283.77 | +54.77% | 22 qtrssince 2019-Q1 | Increased 77 |
NVIDIA Corp. | 6.8M | $837.9M | 16.5% | $64.13 | +92.10% | 3 qtrssince 2023-Q4 | Increased 100 |
Apple Inc. | 3.6M | $762.3M | 15.0% | $134.07 | +55.61% | 22 qtrssince 2019-Q1 | Increased 78 |
AMAZON COM INC | 2.3M | $452.8M | 8.9% | $130.19 | +48.44% | 19 qtrssince 2019-Q4 | Increased 77 |
Alphabet Inc. | 1.5M | $272.4M | 5.3% | $114.34 | +57.98% | 22 qtrssince 2019-Q1 | Increased 76 |
Alphabet Inc. | 1.4M | $256.5M | 5.0% | $113.54 | +60.21% | 22 qtrssince 2019-Q1 | Increased 78 |
Eli Lilly & Co. | 213,690 | $193.5M | 3.8% | $627.16 | +42.17% | 3 qtrssince 2023-Q4 | Increased 70 |
Broadcom Inc | 111,519 | $179M | 3.5% | $157.30 | 0.00% | 1 qtr | New 87 |
Procter and Gamble Co. | 1M | $165M | 3.2% | $141.15 | +10.04% | 3 qtrssince 2023-Q4 | Increased 71 |
Baker Hughes Company | 4.5M | $158.2M | 3.1% | $32.26 | +4.36% | 2 qtrssince 2024-Q1 | Increased 73 |
JPMorgan Chase & Co. | 770,221 | $155.8M | 3.1% | $166.75 | +15.76% | 3 qtrssince 2023-Q4 | Increased 71 |
Tesla Inc | 717,326 | $141.9M | 2.8% | $234.62 | -15.66% | 3 qtrssince 2023-Q4 | Increased 68 |
VISA INC | 501,364 | $131.6M | 2.6% | $270.28 | -4.52% | 2 qtrssince 2024-Q1 | Increased 68 |
UnitedHealth Group Inc. | 247,174 | $125.9M | 2.5% | $492.91 | -1.85% | 3 qtrssince 2023-Q4 | Increased 66 |
Costco Wholesale Corporation | 134,890 | $114.7M | 2.3% | $839.55 | 0.00% | 1 qtr | New 81 |
MasterCard Incorporated | 252,116 | $111.2M | 2.2% | $435.27 | 0.00% | 1 qtr | New 81 |
Merck & Co., Inc | 813,842 | $100.8M | 2.0% | $115.20 | 0.00% | 1 qtr | New 71 |
Cardano Risk Management B.V. manages $5.1B across 17 positions as of Q2 2024. Top holdings: MSFT (18.3%), NVDA (16.5%), AAPL (15.0%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4.5/5.0.
Added 4 new positions, increased 13. Top move: NVDA (INCREASED, conviction 100). Portfolio: $5.1B across 17 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR